| Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse RM Shapiro, GC Birch, G Hu, JV Cadavid, S Nikiforow, J Baginska, AK Ali, ... The Journal of clinical investigation 132 (11), 2022 | 64 | 2022 |
| Key aspects of the immunobiology of haploidentical hematopoietic cell transplantation SHC Baumeister, B Rambaldi, RM Shapiro, R Romee Frontiers in Immunology 11, 504873, 2020 | 48 | 2020 |
| Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active JS Garcia, HT Kim, HM Murdock, CS Cutler, J Brock, M Gooptu, VT Ho, ... Blood Advances 5 (24), 5536-5545, 2021 | 29 | 2021 |
| Therapeutic options for steroid-refractory acute and chronic GVHD: an evolving landscape RM Shapiro, JH Antin Expert Review of Hematology 13 (5), 519-532, 2020 | 29 | 2020 |
| Systematic review of azacitidine regimens in myelodysplastic syndrome and acute myeloid leukemia RM Shapiro, A Lazo-Langner BMC hematology 18, 1-9, 2018 | 29 | 2018 |
| Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution K Maurer, HT Kim, TM Kuczmarski, HM Garrity, A Weber, CG Reynolds, ... Blood Advances 5 (23), 5140-5149, 2021 | 28 | 2021 |
| Next-generation sequencing-based minimal residual disease monitoring in patients receiving allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia or … RM Shapiro, DDH Kim Current Opinion in Hematology 25 (6), 425-432, 2018 | 27 | 2018 |
| Innovative strategies to improve the clinical application of NK cell-based immunotherapy M Tarannum, R Romee, RM Shapiro Frontiers in Immunology 13, 859177, 2022 | 24 | 2022 |
| Eculizumab as a bridge to immunosuppressive therapy in severe cold agglutinin disease of anti-Pr specificity R Shapiro, I Chin-Yee, S Lam Clinical Case Reports 3 (11), 942, 2015 | 24 | 2015 |
| Ibrutinib in steroid-refractory chronic graft-versus-host disease, a single-center experience KK Chin, HT Kim, EA Inyang, V Ho, J Koreth, R Romee, M Gooptu, ... Transplantation and Cellular Therapy 27 (12), 990. e1-990. e7, 2021 | 22 | 2021 |
| GM-CSF secreting leukemia cell vaccination for MDS/AML after allogeneic HSCT: a randomized, double-blinded, phase 2 trial VT Ho, HT Kim, J Brock, I Galinsky, H Daley, C Reynolds, A Weber, ... Blood Advances 6 (7), 2183-2194, 2022 | 15 | 2022 |
| Extensive bone marrow necrosis in a case of acute myeloid leukemia transformed from a myeloproliferative neoplasm R Shapiro, K Rizkalla, S Lam Case Reports in Oncology 8 (2), 345-348, 2015 | 12 | 2015 |
| Posttransplant cyclophosphamide vs tacrolimus–based GVHD prophylaxis: lower incidence of relapse and chronic GVHD K Maurer, VT Ho, E Inyang, C Cutler, J Koreth, RM Shapiro, M Gooptu, ... Blood Advances 7 (15), 3903-3915, 2023 | 10 | 2023 |
| Cytokine-induced memory-like NK cells exhibit massive expansion and long-term persistence after infusion post-haploidentical stem cell transplantation: a report of the first … RM Shapiro, S Nikiforow, B Rambaldi, J Vergara, H Daley, HT Kim, ... Blood 136, 8-9, 2020 | 8 | 2020 |
| Invasive yeast infection after haploidentical donor hematopoietic cell transplantation associated with cytokine release syndrome JS Little, RM Shapiro, MM Aleissa, A Kim, JBP Chang, DW Kubiak, ... Transplantation and cellular therapy 28 (8), 508. e1-508. e8, 2022 | 7 | 2022 |
| Initial transfusion intensity predicts survival in myelodysplastic syndrome LSA Chan, R Shapiro, R Buckstein, Y Lin, J Callum, L Chodirker, CD Lee, ... Leukemia & Lymphoma 55 (10), 2296-2300, 2014 | 7 | 2014 |
| Lower incidence of chronic GVHD observed after transplantation with cryopreserved unrelated allogeneic stem cells K Maurer, HT Kim, HM Garrity, D Liney, C Cutler, JH Antin, J Koreth, J Ritz, ... Blood Advances 7 (11), 2431, 2023 | 6 | 2023 |
| The natural killer cell immunotherapy platform: An overview of the landscape of clinical trials in liquid and solid tumors S Piccinelli, R Romee, RM Shapiro Seminars in Hematology 60 (1), 42-51, 2023 | 6 | 2023 |
| Blastic plasmacytoid dendritic cell neoplasm: a review of diagnosis, pathology, and therapy R Shapiro, N Sangle, M Keeney, IH Chin-Yee, CC Hsia, S Lam J Cell Sci Ther 8, 008, 2015 | 4 | 2015 |
| Opportunistic Infections in Patients Receiving Post-Transplantation Cyclophosphamide: Impact of Haploidentical versus Unrelated Donor Allograft JS Little, R Duléry, RM Shapiro, MM Aleissa, SE Prockop, J Koreth, J Ritz, ... Transplantation and Cellular Therapy 30 (2), 233. e1-233. e14, 2024 | 3 | 2024 |
